Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Reinnervate, Mirus Bio collaborate on 3D transfection system

By R&D Editors | November 16, 2011

Reinnervate
and Mirus Bio announced a commercial agreement to launch a new range of
products for the transfection of cells cultured in 3D.

Under the
agreement, Mirus will produce and sell kits combining TransIT-3D Transfection
Reagent, alvetex 3D cell culture plates, and detailed protocols for achieving
transfection of selected cell lines growing in 3D.

The kits
will enable scientists to evaluate the growth of cells in 3D, allowing more
native cell structure, morphology, and functionality before transfection with a
specific gene of interest with a robust transfection protocol.

“Scientists
are increasingly looking for in-vitro
cell-based assays that better mimic and predict complex biological processes,”
comments Richard Rowling, commercial director at Reinnervate. “We believe the
3D Transfection System will be of broad appeal for cell biologists seeking to
improve their research capabilities beyond the limitations of mono-layer
culture. We are delighted to be collaborating with Mirus to help make 3D cell
culture a more routine laboratory technique.”

Reinnervate, www.reinnervate.com

Related Articles Read More >

2022 Global Funding Forecast: Strong R&D growth with clouds on the horizon
2022 Global Funding Forecast: R&D variants cover more than the pandemic
R&D firm BourkeHood helps startups claim over $100M
2022 R&D 100 Awards now open for submissions
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars